A Sample-Size-Optimal Bayesian Procedure for Sequential Pharmaceutical Trials
From MaRDI portal
Publication:4842862
DOI10.2307/2532784zbMath0822.62091OpenAlexW1562027895WikidataQ47369985 ScholiaQ47369985MaRDI QIDQ4842862
Publication date: 11 September 1995
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2532784
optimal stoppingclinical trialsbackward inductionpredictive distributiongroup-sequential procedurepharmaceutical trialsample- size ruleVPRT
Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian inference (62F15) Sequential statistical analysis (62L10)
Related Items (2)
Methodology and application of adaptive and sequential approaches in contemporary clinical trials ⋮ Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes
This page was built for publication: A Sample-Size-Optimal Bayesian Procedure for Sequential Pharmaceutical Trials